Immutable evidence record · ticker

Prestige BioPharma Limited (950210)

Published as observed on 12 August 2026 at 01:57 BST.

Prestige BioPharma Limited has a balanced company news read. Its latest completed weekly trend is negative.

As of
12 Aug 2026, 01:57
Scope
company and instrument
Evidence
1 items
Independent sources
1
Country
South Korea
Sector
Healthcare
Previous read
47.000
Change
3.000

Verification

Evidence links

This is dated market research. Coverage may be delayed, incomplete or unavailable.

Cite this record:
Sharemaestro, Prestige BioPharma Limited (950210), 2026-08-12, https://sharemaestro.com/evidence/950a7e0f-642d-424a-befb-dfec9582ddb9/
Record checksum 1f3cf36579ebafa91e859d14fd1bbb70262f09f8e56ee80f5c81929c43dcd92e

Evidence context